compounding semaglutide fda enforcement news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA alerts health care providers,

they can also improve metabolic health by lowering inflammation in the body and boosting weight loss, which can make it easier to manage the condition

Key Takeaways No, retatrutide is not FDA-approved

Dairy options like Greek yogurt, skyr, and kefir naturally combine protein and calcium, which helps your body feel fuller and more satisfied after meals

Theres a distinct difference between purity and potency, says Lambert

Since May 2018, she has been contributing to Medical Dialogues, writing and editing medical news articles that translate complex research into clear, accessible information for healthcare professionals

Back Mller, MU, Preker, A (4 Jan 2024) 'Interview with weight loss drugs inventor Lotte Bjerre Knudsen', Spiegel International